Zedott 30 DT Tablet contains Racecadotril 30 mg as its active ingredient and is indicated for the symptomatic treatment of acute diarrhea. Racecadotril is an enkephalinase inhibitor that acts by reducing the secretion of water and electrolytes into the intestinal lumen, thereby decreasing stool output without affecting intestinal motility. This mechanism helps in controlling diarrhea while preserving normal bowel function. Zedott 30 DT is formulated as a dispersible tablet, allowing for rapid dissolution and ease of administration, particularly beneficial for pediatric and geriatric patients who may have difficulty swallowing conventional tablets. It is typically prescribed as an adjunct to oral rehydration therapy to prevent dehydration and restore electrolyte balance. The recommended dosage and duration of treatment should be adhered to as per the prescribing physician’s instructions. Common adverse effects are generally mild and may include headache, rash, or gastrointestinal discomfort. Zedott 30 DT should be used with caution in patients with known hypersensitivity to Racecadotril or any excipients present in the formulation. It is contraindicated in cases of chronic diarrhea and should not replace appropriate medical evaluation in persistent or severe cases. Proper storage conditions should be maintained to ensure drug stability and efficacy.